For the Inventor, By the Inventor

Enter assignee name

Seattle, WA, United States of America

Etubics Corporation

USPTO Granted Patents = 19

EPO Patents = 5

Forward Citations = 67

Loading Chart...

Loading Chart...

7 inventors (with patents filed for the assignee):

Frank R Jones (19 out of 26 patents)

Joseph P Balint (14 out of 24 patents)

Elizabeth Gabitzsch (10 out of 10 patents)

4. Richard B Gayle (6 out of 6 patents)

5. Yvette Latchman (6 out of 7 patents)

6. Adrian Rice (6 out of 6 patents)

7. Richard B Gayle, Iii (3 out of 6 patents)

8. Richard B Iii Gayle (0 patent)

9. Richard B Iii Gayle (0 patent)

19 patents: Sort by Forward Citations

1. 12370250 - Methods and compositions for producing an adenovirus vector for use with multiple vaccinations (2025-07-29),

2. 11826417 - Methods and compositions for producing an adenovirus vector for use with multiple vaccinations (2023-11-28),

3. 11529408 - Methods and compositions for producing an adenovirus vector for use with multiple vaccinations (2022-12-20),

4. 11504423 - Methods and compositions for producing an adenovirus vector for use with multiple vaccinations (2022-11-22),

5. 11389521 - Methods and compositions for producing an adenovirus vector for use with multiple vaccinations (2022-07-19),

6. 11376316 - Breast cancer vaccines and methods of use thereof (2022-07-05),

7. 11369673 - HPV vaccines and methods of use thereof (2022-06-28),

8. 11352642 - Methods and compositions for combination immunotherapy (2022-06-07),

9. 11344613 - Sequential administration of a replication defective adenovirus vector in vaccination protocols (2022-05-31),

10. 11304998 - Combination immunotherapies comprising IL-15 superagonists (2022-04-19),

11. 11149087 - Methods and compositions for combination immunotherapy (2021-10-19),

12. 11116827 - Compositions and methods for tumor vaccination and immunotherapy involving HER antigens (2021-09-14),

13. 11104916 - Compositions and methods for alphavirus vaccination (2021-08-31),

14. 11020467 - Combination immunotherapies comprising IL-15 superagonists (2021-06-01),

15. 10835596 - Compositions and methods for flavivirus vaccination (2020-11-17),

Etubics Corporation is a biotechnology company specializing in the development of cutting-edge therapeutics and diagnostics. Our mission is to revolutionize healthcare through innovative gene therapy solutions. With a focus on advancing personalized medicine, Etubics is at the forefront of translating breakthrough genetic research into practical applications for patients. Our team of experienced scientists and clinicians are dedicated to transforming the lives of individuals affected by genetic diseases. Visit our website to learn more about our groundbreaking work and the impact we are making in the field of biotechnology.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

19 Patents

#95 in Seattle, WA

#348 in Washington

#16,629 in US

#31,713 in the World

Seattle, WA, United States of America

Etubics Corporation

Forward Citations = 67

7 inventors:

Frank R Jones (19 out of 26 patents)

Joseph P Balint (14 out of 24 patents)

Elizabeth Gabitzsch (10 out of 10 patents)

4. Richard B Gayle (6 out of 6 patents)

5. Yvette Latchman (6 out of 7 patents)

Please report any incorrect information to support@idiyas.com

Loading…